BORGO, CHRISTIAN
 Distribuzione geografica
Continente #
NA - Nord America 3.564
AS - Asia 1.257
EU - Europa 965
SA - Sud America 292
AF - Africa 262
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 9
Totale 6.373
Nazione #
US - Stati Uniti d'America 3.417
SG - Singapore 379
CN - Cina 340
IT - Italia 245
BR - Brasile 211
HK - Hong Kong 183
DE - Germania 93
SE - Svezia 92
VN - Vietnam 91
FI - Finlandia 84
PL - Polonia 56
CI - Costa d'Avorio 53
NL - Olanda 53
FR - Francia 48
GB - Regno Unito 34
RU - Federazione Russa 29
UA - Ucraina 28
AT - Austria 23
IN - India 22
KR - Corea 21
TR - Turchia 20
AR - Argentina 17
CA - Canada 17
IE - Irlanda 14
SA - Arabia Saudita 14
EC - Ecuador 12
ES - Italia 12
HN - Honduras 12
UG - Uganda 12
BE - Belgio 11
GT - Guatemala 11
MU - Mauritius 11
MX - Messico 11
ZW - Zimbabwe 11
AL - Albania 10
JO - Giordania 10
JP - Giappone 10
MR - Mauritania 10
PK - Pakistan 10
UY - Uruguay 10
ZA - Sudafrica 10
BZ - Belize 9
CR - Costa Rica 9
IL - Israele 9
IQ - Iraq 9
LA - Repubblica Popolare Democratica del Laos 9
LV - Lettonia 9
BG - Bulgaria 8
BO - Bolivia 8
CH - Svizzera 8
CV - Capo Verde 8
GF - Guiana Francese 8
GR - Grecia 8
JM - Giamaica 8
PS - Palestinian Territory 8
PY - Paraguay 8
RS - Serbia 8
YT - Mayotte 8
AE - Emirati Arabi Uniti 7
BB - Barbados 7
CU - Cuba 7
DK - Danimarca 7
HR - Croazia 7
KG - Kirghizistan 7
KZ - Kazakistan 7
LY - Libia 7
MG - Madagascar 7
NC - Nuova Caledonia 7
NI - Nicaragua 7
PE - Perù 7
RO - Romania 7
TH - Thailandia 7
AO - Angola 6
AU - Australia 6
AZ - Azerbaigian 6
BD - Bangladesh 6
BW - Botswana 6
BY - Bielorussia 6
CW - ???statistics.table.value.countryCode.CW??? 6
CY - Cipro 6
GA - Gabon 6
GN - Guinea 6
ID - Indonesia 6
IS - Islanda 6
KE - Kenya 6
KH - Cambogia 6
LB - Libano 6
LC - Santa Lucia 6
MA - Marocco 6
MN - Mongolia 6
PA - Panama 6
PR - Porto Rico 6
SD - Sudan 6
TT - Trinidad e Tobago 6
VC - Saint Vincent e Grenadine 6
YE - Yemen 6
AF - Afghanistan, Repubblica islamica di 5
BF - Burkina Faso 5
BJ - Benin 5
CD - Congo 5
Totale 6.161
Città #
Fairfield 514
Ashburn 406
Woodbridge 324
Chandler 292
Singapore 249
Houston 213
Seattle 209
Wilmington 198
Cambridge 182
Hong Kong 178
Ann Arbor 144
Beijing 88
Padova 84
Boardman 69
Abidjan 52
Bytom 52
Santa Clara 52
Des Moines 47
Helsinki 47
Princeton 45
Jacksonville 43
Medford 41
San Diego 40
Dong Ket 39
Los Angeles 39
Munich 36
Nanjing 31
New York 30
Hefei 18
Roxbury 18
São Paulo 18
Ho Chi Minh City 17
Shenyang 16
Cagliari 15
Guangzhou 15
Jinan 14
Turku 14
Dublin 12
Hanoi 12
Kampala 12
Nanchang 12
Nuremberg 12
Brooklyn 11
Buffalo 11
Seoul 11
Amman 10
Vienna 10
Guatemala City 9
Harare 9
Nouakchott 9
Milan 8
Montevideo 8
Ningbo 8
Tianjin 8
Vientiane 8
Brasília 7
Bridgetown 7
Cayenne 7
Changsha 7
Chicago 7
Havana 7
Johannesburg 7
Kharkiv 7
Managua 7
Noumea 7
Praia 7
Riga 7
Antananarivo 6
Athens 6
Bologna 6
Boston 6
Castries 6
Ciudad del Este 6
Conakry 6
Council Bluffs 6
Curitiba 6
Falls Church 6
Hebei 6
Istanbul 6
Kingstown 6
Libreville 6
London 6
Luanda 6
Nairobi 6
Naples 6
Panama City 6
Phnom Penh 6
Redondo Beach 6
San Francisco 6
San Pedro Sula 6
Sofia 6
Tokyo 6
Ulan Bator 6
Aden 5
Almaty 5
Baku 5
Bishkek 5
Brussels 5
Dar es Salaam 5
Falkenstein 5
Totale 4.344
Nome #
CK2 modulates adipocyte insulin-signaling and is up-regulated in human obesity 261
Protein kinase CK2 potentiates translation efficiency by phosphorylating eIF3j at Ser127. 211
Protein kinase CK2 is involved in adipose tissue insulin signaling and remodeling during obesity and weight loss 203
Re-evaluation of protein kinase CK2 pleiotropy: new insights provided by a phosphoproteomics analysis of CK2 knockout cells 195
A journey through the cytoskeleton with protein kinase CK2 195
A proteomics analysis of CK2β(-/-) C2C12 cells provides novel insights into the biological functions of the non-catalytic β subunit 193
Protein kinase CK2 subunits exert specific and coordinated functions in skeletal muscle differentiation and fusogenic activity 191
CK2 is a key regulator of SLC4A2-mediated Cl-/HCO3 (-) exchange in human airway epithelia 186
Dependence of HSP27 cellular level on protein kinase CK2 discloses novel therapeutic strategies 179
Aberrant signalling by protein kinase CK2 in imatinib-resistant chronic myeloid leukaemia cells. Biochemical evidence and therapeutic perspectives 168
Exploring the CK2 paradox: Restless, dangerous, dispensable 152
Generation and quantitative proteomics analysis of CK2α/α'(-/-) cells 150
Role of protein kinase CK2 in antitumor drug resistance 147
Effects of the CK2 inhibitors CX-4945 and CX-5011 on drug-resistant cells 144
A N-terminally deleted form of the CK2 alpha' catalytic subunit is sufficient to support cell viability 139
White adipose tissue expansion in multiple symmetric lipomatosis is associated with upregulation of ck2, akt and erk1/2 137
Effects of CK2β subunit down-regulation on Akt signalling in HK-2 renal cells 133
The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells 131
Deciphering the role of protein kinase CK2 in the maturation/stability of F508del-CFTR 128
The protein kinase CK2 contributes to the protumorigenic properties of cholangiocarcinoma cells 127
“Janus” efficacy of CX-5011: CK2 inhibition and methuosis induction by independent mechanisms 125
Protein kinase CK2 inhibition as a pharmacological strategy 124
Protein kinase CK2: a potential therapeutic target for diverse human diseases 124
Synthesis and Evaluation of Platelet Aggregation Inhibitory Activity of Some 3-Phenyl-pyrroloquinazolinones 122
Coinvolgimento della proteinchinasi CK2 nella resistenza all’imatinib in cellule di leucemia mieloide cronica 115
J-SUBUNIT OF THE EUKARYOTIC INITIATION FACTOR 3 IS A NEW SUBSTRATE OF PROTEIN KINASE CK2 112
Contribution of the CK2 Catalytic Isoforms α and α’ to the Glycolytic Phenotype of Tumor Cells 110
Coinvolgimento della proteinchinasi CK2 nella resistenza all'imatinib in cellule di leucemia mieloide cronica 106
null 105
Comparing the efficacy and selectivity of Ck2 inhibitors. A phosphoproteomics approach 105
Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy - potential clinical relevance 101
Protein kinase CK2: a new target to overcome imatinib-resistance in CML cells 100
HOW PROTEIN KINASE CK2 IS INVOLVED IN IMATINIB-RESISTANT CHRONIC MYELOID LEUKEMIA CELLS? 99
Mechanism of CK2 Inhibition by a Ruthenium-Based Polyoxometalate 97
Aberrant Signalling by Protein Kinase CK2 in Imatinib-resistant Chronic Myeloid Laeukemia Cells 97
Protein kinase CK2 subunits differentially perturb the adhesion and migration of GN11 cells: A model of immature migrating neurons 96
How can a traffic light properly work if it is always green? The paradox of CK2 signaling 93
Modulation of protein kinases in the regulation of chaperone machinery leading F508-del-CFTR fate - The Proceedings of the 16th Italian Convention of Investigators in Cystic Fibrosis 91
Targeting protein kinase CK2 to overcome imatinib-resitance 90
Critical role of protein kinase CK2 in chronic myeloid leukemia cells harboring the T315I BCR::ABL1 mutation 84
INVOLVEMENT OF THE PROTEIN KINASE CK2 AND ITS INTERACTOME IN IMATINIB SENSITIVE AND RESISTANT CHRONIC MYELOID LEUKEMIA CELLS 84
The protein kinase ck2 associates with and phosphorylates the eukaryotic initiation factor 3 84
A mutational approach to dissect the functional role of the putative CFTR “PTM-CODE” 84
Transport of serotonin into human platelets is regulated by tyrosinephosphorylation of SERT and its interaction with integrin-alphaII/beta3 79
Targeting CK2 in cancer: a valuable strategy or a waste of time? 78
Analysis of the phosphoproteome of CK2α(-/-)/Δα' C2C12 myoblasts compared to the wild-type cells 76
Regulation of serotonin transport in human platelets by tyrosine kinase Syk 73
Targeting the E1 ubiquitin-activating enzyme (UBA1) improves elexacaftor/tezacaftor/ivacaftor efficacy towards F508del and rare misfolded CFTR mutants 73
Targeting ubiquitination machinery in cystic fibrosis: Where do we stand? 71
Involvement of Protein Kinase CK2 in Imatinib-resistant Chronic Myeloid Leukemia Cells 69
null 68
null 66
SUMOylation Inhibition Enhances Protein Transcription under CMV Promoter: A Lesson from a Study with the F508del-CFTR Mutant 59
KDM2A and KDM3B as Potential Targets for the Rescue of F508del-CFTR 51
Regulation of the cell secretome by protein kinase CK2 modulates cell migration and extracellular matrix composition 17
null 8
Totale 6.506
Categoria #
all - tutte 22.982
article - articoli 20.078
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.060


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021736 0 0 73 47 46 31 66 43 94 155 72 109
2021/2022672 18 66 71 70 50 54 24 52 36 27 65 139
2022/2023537 84 79 6 70 82 75 5 29 55 6 30 16
2023/2024320 21 46 38 25 38 27 21 30 8 16 21 29
2024/20251.425 9 60 51 73 123 69 119 118 147 36 248 372
2025/20261.426 373 422 631 0 0 0 0 0 0 0 0 0
Totale 6.506